Jade Jones

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Mohammed Farooqui, Janet Valdez, Sabrina Martyr et al. · The Lancet Oncology · 2014 · 366 citations · Full text

Medicine, Immunology, Oncology +11

Disruption of <i>in vivo</i> Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study

Carsten Utoft Niemann, Sarah E. M. Herman, Irina Marić et al. · Clinical Cancer Research · 2015 · 194 citations · Full text

Medicine, Immunology, Oncology +17

Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells <i>In Vivo</i>

Sarah E. M. Herman, Rashida Z. Mustafa, Jade Jones et al. · Clinical Cancer Research · 2015 · 106 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Knowledge about human papillomavirus and the HPV vaccine – a survey of the general population

Camille Ragin, Robert P. Edwards, Jade Jones et al. · Infectious Agents and Cancer · 2009 · 69 citations · Full text

Veterinary Medicine, Health Education, Preventive Medicine +17

Multicenter Study of Human Papillomavirus and the Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African Descent

Elizabeth Blackman, Natalie Thurman, Darron Halliday et al. · Infectious Diseases in Obstetrics and Gynecology · 2013 · 23 citations · Full text

Medicine, Health Behavior, Preventive Medicine +17